238 related articles for article (PubMed ID: 8855981)
1. Differential responses of scirrhous and well-differentiated gastric cancer cells to orthotopic fibroblasts.
Yashiro M; Chung YS; Kubo T; Hato F; Sowa M
Br J Cancer; 1996 Oct; 74(7):1096-103. PubMed ID: 8855981
[TBL] [Abstract][Full Text] [Related]
2. Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma.
Nakazawa K; Yashiro M; Hirakawa K
Cancer Res; 2003 Dec; 63(24):8848-52. PubMed ID: 14695201
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells.
Inoue T; Chung YS; Yashiro M; Nishimura S; Hasuma T; Otani S; Sowa M
Jpn J Cancer Res; 1997 Feb; 88(2):152-9. PubMed ID: 9119743
[TBL] [Abstract][Full Text] [Related]
4. Role of orthotopic fibroblasts in the development of scirrhous gastric carcinoma.
Yashiro M; Chung YS; Sowa M
Jpn J Cancer Res; 1994 Sep; 85(9):883-6. PubMed ID: 7961114
[TBL] [Abstract][Full Text] [Related]
5. Influence of hepatocyte growth factor secreted from fibroblasts on the growth and invasion of scirrhous gastric cancer.
Murakami N; Koufuji K; Shirouzu K
Int Surg; 2001; 86(3):151-7. PubMed ID: 11996071
[TBL] [Abstract][Full Text] [Related]
6. Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Cancer; 1996 Apr; 77(8 Suppl):1668-75. PubMed ID: 8608560
[TBL] [Abstract][Full Text] [Related]
7. [Gastric scirrhous carcinoma and growth factors].
Tahara E; Nakatani H; Yoshida K; Yokozaki H
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1236-40. PubMed ID: 2837983
[TBL] [Abstract][Full Text] [Related]
8. [Pathogenesis and progression of scirrhous carcinoma].
Naito Y; Kino I
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2364-70. PubMed ID: 7944478
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of cancer-associated myofibroblasts by TGF-β from scirrhous gastric carcinoma cells.
Fuyuhiro Y; Yashiro M; Noda S; Kashiwagi S; Matsuoka J; Doi Y; Kato Y; Hasegawa T; Sawada T; Hirakawa K
Br J Cancer; 2011 Sep; 105(7):996-1001. PubMed ID: 21863023
[TBL] [Abstract][Full Text] [Related]
10. Selective cyclooxygenase-2 inhibitor downregulates the paracrine epithelial-mesenchymal interactions of growth in scirrhous gastric carcinoma.
Yashiro M; Nakazawa K; Tendo M; Kosaka K; Shinto O; Hirakawa K
Int J Cancer; 2007 Feb; 120(3):686-93. PubMed ID: 17096355
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta1 secreted by gastric fibroblasts up-regulates CD44H expression and stimulates the peritoneal metastatic ability of scirrhous gastric cancer cells.
Koyama T; Yashiro M; Inoue T; Nishimura S; Hirakawa-YS Chung K
Int J Oncol; 2000 Feb; 16(2):355-62. PubMed ID: 10639581
[TBL] [Abstract][Full Text] [Related]
12. Establishment of two new scirrhous gastric cancer cell lines: analysis of factors associated with disseminated metastasis.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Br J Cancer; 1995 Nov; 72(5):1200-10. PubMed ID: 7577468
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of a selective cyclooxygenase inhibitor on the invasion-stimulating activity of orthotopic fibroblasts for scirrhous gastric cancer cells.
Tendo M; Yashiro M; Nakazawa K; Yamada N; Hirakawa K
Cancer Sci; 2005 Jul; 96(7):451-5. PubMed ID: 16053517
[TBL] [Abstract][Full Text] [Related]
14. An in-vitro model of scirrhous carcinoma of the stomach using stomach fibroblasts derived from gastric cancer patients.
Kikuchi S; Sato T; Arai Y; Tsutsumi O; Hiki Y; Kakita A
Hepatogastroenterology; 2000; 47(35):1256-9. PubMed ID: 11100326
[TBL] [Abstract][Full Text] [Related]
15. [Genetic characteristics of scirrhous gastric carcinomas].
Yokozaki H; Kuniyasu H; Yasui W; Tahara E
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2371-7. PubMed ID: 7944479
[TBL] [Abstract][Full Text] [Related]
16. Globotriaosyl ceramide and globoside as major glycolipid components of fibroblasts in scirrhous gastric carcinoma tissues.
Sawada R; Hotta H; Chung YS; Sowa M; Tai T; Yano I
Jpn J Cancer Res; 1998 Feb; 89(2):167-76. PubMed ID: 9548444
[TBL] [Abstract][Full Text] [Related]
17. Tranilast (N-(3,4-dimethoxycinnamoyl) anthranilic acid) down-regulates the growth of scirrhous gastric cancer.
Yashiro M; Chung YS; Sowa M
Anticancer Res; 1997; 17(2A):895-900. PubMed ID: 9137424
[TBL] [Abstract][Full Text] [Related]
18. [Mechanisms responsible for the progression of scirrhous gastric cancer].
Yashiro M; Ohira M; Muguruma K; Shinto O; Hirakawa K
Nihon Rinsho; 2012 Oct; 70(10):1812-6. PubMed ID: 23198567
[TBL] [Abstract][Full Text] [Related]
19. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma.
Kawajiri H; Yashiro M; Shinto O; Nakamura K; Tendo M; Takemura S; Node M; Hamashima Y; Kajimoto T; Sawada T; Ohira M; Hirakawa K
Clin Cancer Res; 2008 May; 14(9):2850-60. PubMed ID: 18451253
[TBL] [Abstract][Full Text] [Related]
20. Effects of transforming growth factor-beta released from gastric carcinoma cells on the contraction of collagen-matrix gels containing fibroblasts.
Ura H; Obara T; Yokota K; Shibata Y; Okamura K; Namiki M
Cancer Res; 1991 Jul; 51(13):3550-4. PubMed ID: 1647270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
